Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests-Reference-Cited by-同舟云学术

Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests

Published:2017-06-01 Issue:2 Volume:178 Page:220-230
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Heaney Jennifer L. J.¹^ORCID,Campbell John P.¹,Griffin Anne E.¹,Birtwistle Jane¹,Shemar Meena²,Child J Anthony³,Gregory Walter M.³,Cairns David A.³,Morgan Gareth⁴,Jackson Graham⁵,Drayson Mark T.¹

Affiliation:

1. Clinical Immunology Service; Institute of Immunology and Immunotherapy; University of Birmingham; Birmingham UK

2. Abingdon Health Ltd.; York UK

3. Clinical Trials Research Unit; University of Leeds; Leeds UK

4. The Myeloma Institute; University of Arkansas for Medical Sciences; Little Rock AR USA

5. University of Newcastle; Newcastle-upon-Tyne UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14753/fullpdf

Reference23 articles.

1. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine;Bradwell;Clincal Chemistry,2001

2. Serum test for assessment of patients with Bence Jones myeloma;Bradwell;Lancet,2003

3. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine;Campbell;Journal of Immunological Methods,2013

4. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum kappa and lambda immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool;Campbell;Clinical Chemistry Laboratory Medicine,2017

5. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma;Dejoie;Haematologica,2016a

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian Cohort;Indian Journal of Hematology and Blood Transfusion;2024-09-05

2. Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry;Blood Cancer Journal;2024-03-18

3. Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies;Antibodies;2024-03-11

4. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services;British Journal of Haematology;2024-01-02

5. Machine Learning Approach for Rapid, Accurate Point-of-Care Prediction of M-Spike Values in Multiple Myeloma;JCO Clinical Cancer Informatics;2023-09